‘South Africa must follow India, China lead on affordable life-saving drugs’
Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited
Cipla to continue slashing cancer drug prices
Bayer challenges 'compulsory license' ruling
Compulsory licensing effect: Cipla slashes price of generic cancer drug by 80%!
Roche Holding plans to launch two blockbuster cut-price cancer drugs in India
‘South Africa must follow India, China lead on affordable life-saving drugs’
Intellectual property board hears Bayer vs compulsory licencing case, verdict awaited
Cipla to continue slashing cancer drug prices
Bayer challenges 'compulsory license' ruling
Compulsory licensing effect: Cipla slashes price of generic cancer drug by 80%!
Roche Holding plans to launch two blockbuster cut-price cancer drugs in India
